Skip to main content
Move the World.
Take a Trip to Johns Hopkins' New Psychedelic Research Center

Johns Hopkins is throwing its considerable clout behind the fast-growing field of psychedelic research, pouring $17 million into a research center to study the hallucinogenic drugs. This is — even by tie-dyed, Deadhead, Timothy Leary, spirit-of-the-60s, let-me-tell-you-about-Burning-Man standards — a lot of money to spend on psychedelics. According to FierceBiotech, the new Center for Psychedelic and Consciousness Research will be the first of its kind in the United States and the largest in the world.

But the data being gathered on the drugs — which include LSD, MDMA, psilocybin, and ketamine, along with an alphabet soup of lesser known compounds — shows promise in a variety of applications. Best known are the possible psychological benefits to psychedelic experiences.

The Promising Potential of Psychedelic Research

Although the field of psychedelic research isn't a new one, the Center has set expectations high for fresh insights and advancements.

"The most exciting is the potential that a psychedelic treatment model may have, particularly when treating clinical conditions for which we don't have effective treatments," says Charles Grob, Professor of Psychiatry and Pediatrics at UCLA's David Geffen School of Medicine.

These can include conditions like depression and addiction. Grob recently co-authored a pilot study looking at using MDMA for treating social anxiety in adults with autism.

Dried psilocybin mushrooms.

Dried psilocybin mushrooms. Psilocybin, the active ingredient in "magic mushrooms", is one of the compounds being studied for its potential for treating conditions like depression and addiction. Photo by © Andrea / Adobe Stock

Wilder still, psychedelics may have impacts outside of the brain and central nervous system.

Charles Nichols, a professor in the Department of Pharmacology and Experimental Therapeutics at LSU Health Medical Center, has found that the psychedelic compound DOI (structurally similar to mescaline) has anti-inflammatory effects — a bizarre discovery, Grob laughs, that came out of left field. Nichols' tests in cell, mouse, and rat models show that a very small dose of the drug has a major impact on inflammation.

“When centers like Hopkins attract this money, it's a validation of the field as being legitimate.”

Charles Nichols, a professor in the Department of Pharmacology and Experimental Therapeutics at LSU Health Medical Center

"The neat thing about this," Nichols says, "is that some of the drugs we've looked at are very potent at producing these anti-inflammatory effects," meaning that they may work at doses well below the threshold that would cause a patient to trip.

Johns Hopkins' Psychedelic Research is Just Beginning

Psychedelic research, while promising, still has a long way to go to make up for the lost time that was collateral damage of the culture war of the 1960s. Both Grob and Nichols point to the credibility and respect Johns Hopkins commands as being key for advancing the field, even beyond the research that the center will eventually support and publish. (The large investment to fund the Center doesn't hurt, either.)

“The most exciting is the potential that a psychedelic treatment model may have, particularly when treating clinical conditions for which we don't have effective treatments,”

Charles Grob, Professor of Psychiatry and Pediatrics at UCLA's David Geffen School of Medicine.

"I think this is very big," says Grob, who admits to being a bit biased about Hopkins — he trained there, worked there, and was even born there.

But Nichols agrees.

"When centers like Hopkins attract this money, it's a validation of the field as being legitimate."

Up Next

Public Health
A List of the Coronavirus Symptoms, and When to See a Doctor
what are the coronavirus symptoms
Public Health
A List of the Coronavirus Symptoms, and When to See a Doctor
Here is the latest information on coronavirus symptoms and how to distinguish COVID-19 from allergies, the flu, or a common cold.

Here is the latest information on coronavirus symptoms and how to distinguish COVID-19 from allergies, the flu, or a common cold.

Extreme Weather
New Study Into How Tornadoes Form Could Save Lives
how tornadoes form
Extreme Weather
New Study Into How Tornadoes Form Could Save Lives
To improve our understanding of how tornadoes form, researchers involved in the TORUS Project will send tech straight into supercell thunderstorms.

To improve our understanding of how tornadoes form, researchers involved in the TORUS Project will send tech straight into supercell thunderstorms.

Dispatches
The Gut Microbiome Affects Brain Structure
The Gut Microbiome Affects Brain Structure
Dispatches
The Gut Microbiome Affects Brain Structure
What happens in your gut in childhood can change how your brain works later in life.

What happens in your gut in childhood can change how your brain works later in life.

Dispatches
The Cost of Sucking Carbon Out of the Air Just Fell By 85%
The Cost of Sucking Carbon Out of the Air Just Fell By 85%
Dispatches
The Cost of Sucking Carbon Out of the Air Just Fell By 85%
It's not there yet, but carbon capture just got interesting.

It's not there yet, but carbon capture just got interesting.

Superhuman
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
Watch Now
Superhuman
Can Genetically Modified Pigs Be the Key to Treating Rare Diseases?
When it comes to rare diseases, doctors often don’t have enough patients to determine the effectiveness of various treatments. Now, scientists are breeding pigs with the same genetic code as people with a disease in order to create a pool of test "patients" unlike any before.
Watch Now

There are thousands of diseases known to modern medicine without any cure or treatment. Many are too rare to get much attention from doctors, governments, or drug companies. But the gene editing tool CRISPR is offering hope for people with rare and hard to study diseases, like the genetic disease known as NF1. There are tens of thousands of Americans with this tumor-causing nerve disease, but because it has over 4,000...

On the Cusp
How Virtual Reality is Changing Medicine
How Virtual Reality is Changing Medicine
On the Cusp
How Virtual Reality is Changing Medicine
From virtual hearts to immersive battlefields, doctors and scientists are using virtual reality to transform medicine
By Brandon Stewart

From virtual hearts to immersive battlefields, doctors and scientists are using virtual reality to transform medicine

The New Space Race
Preparing the First Space Colonizers for Life Off of Planet Earth
Preparing the First Space Colonizers for Life Off of Planet Earth
The New Space Race
Preparing the First Space Colonizers for Life Off of Planet Earth
It’s only a matter of time until the average person can explore space. But, will the average person be ready?
By Mike Riggs

It’s only a matter of time until the average person can explore space. But, will the average person be ready?

Superhuman
Meet the Man with the Most Advanced Prosthetic Arm in the World
Meet the Man with the Most Advanced Prosthetic Arm in the World
Superhuman
Meet the Man with the Most Advanced Prosthetic Arm in the World
Johnny Matheny has been working with doctors at Johns Hopkins Applied Physics Lab to test a prosthetic arm that is...
By Mike Riggs

Johnny Matheny has been working with doctors at Johns Hopkins Applied Physics Lab to test a prosthetic arm that is controlled with your thoughts.

Technology
How to Send Mail to a Person With No Address
send mail without address
Technology
How to Send Mail to a Person With No Address
Millions of people have no address. They can’t get mail, they can't vote, they can’t get aid, and they don’t have...
By Mike Riggs

Millions of people have no address. They can’t get mail, they can't vote, they can’t get aid, and they don’t have rights. One company wants to change that.